Cheelcare Inc.
CHER.V
Toronto Stock Exchange Ventures1.44
CAD
+0.01
- -
Cheelcare Inc.
CHER.V
(Toronto Stock Exchange Ventures)
Recent
price
1.44
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Cheelcare Inc. designs, manufactures and commercializes advanced mobility and assistive-technology solutions for individuals with disabilities and complex mobility needs. The Company’s principal products include the Companion line of front-mounted power-assist devices for manual wheelchairs, which provide powered propulsion and are distributed through dealer, clinical and rehabilitation channels; the Curio robotic complex-rehabilitation power wheelchair, which integrates robotic functionality with seating, suspension and control systems; and the AWARE rear-view safety system for wheelchair users. Cheelcare serves end users, clinicians, occupational therapists, rehabilitation dealers, funding agencies, veterans’ healthcare providers and other mobility-equipment stakeholders through a global dealer network comprising more than 500 locations, including more than 200 locations in the United States, 267 locations in Ontario and more than 35 U.S. Veterans Affairs Medical Centers. Founded in 2014, the Company is headquartered in Markham, Ontario, Canada. Recent developments include the commencement of commercial production and initial deliveries of Curio power wheelchairs to paying customers in March 2026; continued engineering refinement and validation of Curio for resubmission to Ontario’s Assistive Devices Program, alongside ongoing U.S. Food and Drug Administration 510(k) premarket-notification activities; U.S. PDAC verification for Companion in January 2026, establishing eligibility for Medicare and Medicaid reimbursement; the transition of production operations to a 16,000-square-foot facility in October 2025; and the completion in July 2026 of a CAD3.02 million non-brokered private placement to fund product development, commercialization and working-capital requirements.